Metraipolis › archive › dc_5e1c4003003e

Immunotherapy in triple-negative breast cancer: mechanisms of resistance and emerging approaches: a narrative review — Europe PMC PMID:41645627

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41645627
DOI
10.12701/jyms.2026.43.17
License (as archived)
solo-consultazione
Archived
2026-11-06T01:29:38.070Z
SHA-256 of the archived text
04ee9ff6a49026c6cf417d506b7858b534166cb43a87d3e6fca0cf6a9973dbd7
Stable URL of this page
https://metraipolis.com/documento/dc_5e1c4003003e

How to cite

Immunotherapy in triple-negative breast cancer: mechanisms of resistance and emerging approaches: a narrative review — Europe PMC PMID:41645627 — Europe PMC (en), https://europepmc.org/article/MED/41645627 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5e1c4003003e (Metraipolis archive dc_5e1c4003003e, sha256 04ee9ff6a49026c6cf417d506b7858b534166cb43a87d3e6fca0cf6a9973dbd7)
BibTeX
@misc{dc5e1c4003003e,
  title = {Immunotherapy in triple-negative breast cancer: mechanisms of resistance and emerging approaches: a narrative review — Europe PMC PMID:41645627},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41645627},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5e1c4003003e; sha256 04ee9ff6a49026c6cf417d506b7858b534166cb43a87d3e6fca0cf6a9973dbd7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41645627. Agents can read the archived copy with the MCP tool read_document.